Abstract
The present studies were performed in an effort to examine the characteristics of the control system governing phosphate excretion in uremic man. In a group of patients with glomerular filtration rates (GFR) ranging from normal to 2 ml/min, it was found that the lower the GFR the lower the fraction of filtered phosphate reabsorbed (TRP). On a fixed phosphate intake, phosphate excretion rate was the same in patients with GFRs ranging from 60 to 3 ml/min. When plasma phosphate concentrations were diminished to subnormal levels in hyperphosphatemic, hypocalcemic uremic patients, TRP values increased but did not return to normal. TRP failed to rise substantially when GFR, as well as plasma phosphate concentrations, were diminished. In patients with unilateral renal disease, TRP values were equal bilaterally, and values were substantially higher in the diseased kidneys than in patients with bilateral involvement. When plasma calcium concentrations were raised to normal for 2-3 wk in uremic patients in whom plasma phosphate concentrations had previously been lowered to subnormal levels, TRP values rose to an average value of 86%. Values remained in the normal range when phosphate concentrations were allowed to increase while normocalcemia was maintained. The data are interpreted to indicate that in advancing renal disease, the changing patterns of phosphate excretion are mediated by a control system in which parathyroid hormone serves as a major effector element. An increase in GFR per nephron, hyperphosphatemia, and intrinsic inability of the surviving nephrons to transport phosphate do not appear to be of primary importance in the progressive reduction in TRP.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berson S. A., Yalow R. S. Radioimmunoassays of peptide hormones in plasma. N Engl J Med. 1967 Sep 21;277(12):640–647. doi: 10.1056/NEJM196709212771208. [DOI] [PubMed] [Google Scholar]
- Copp D. H. Hormonal control of hypercalcemia. Historic development of the calcitonin concept. Am J Med. 1967 Nov;43(5):648–655. doi: 10.1016/0002-9343(67)90105-2. [DOI] [PubMed] [Google Scholar]
- DENT C. E., HARPER C. M., PHILPOT G. R. The treatment of renal-glomerular osteodystrophy. Q J Med. 1961 Jan;30:1–31. [PubMed] [Google Scholar]
- FLETCHER R. F., JONES J. H., MORGAN D. B. BONE DISEASE IN CHRONIC RENAL FAILURE. Q J Med. 1963 Oct;32:321–329. [PubMed] [Google Scholar]
- GOLDMAN R., BASSETT S. H. Phosphorus excretion in renal failure. J Clin Invest. 1954 Dec;33(12):1623–1628. doi: 10.1172/JCI103042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GOODMAN A. D., LEMANN J., Jr, LENNON E. J., RELMAN A. S. PRODUCTION, EXCRETION, AND NET BALANCE OF FIXED ACID IN PATIENTS WITH RENAL ACIDOSIS. J Clin Invest. 1965 Apr;44:495–506. doi: 10.1172/JCI105163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gitelman H. J., Kukolj S., Welt L. G. The influence of the parathyroid glands on the hypercalcemia of experimental magnesium depletion in the rat. J Clin Invest. 1968 Jan;47(1):118–126. doi: 10.1172/JCI105702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemann J., Jr, Litzow J. R., Lennon E. J. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest. 1966 Oct;45(10):1608–1614. doi: 10.1172/JCI105467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MORRIN P. A. PHOSPHATE EXCRETION IN CHRONIC UREMIA WITH OBSERVATIONS ON THE EFFECT OF INTRAVENOUS INFUSION OF CALCIUM. Metabolism. 1965 Jun;14:674–683. doi: 10.1016/0026-0495(65)90050-8. [DOI] [PubMed] [Google Scholar]
- Pellegrino E. D., Biltz R. M. The composition of human bone in uremia. Observations on the reservoir functions of bone and demonstration of a labile fraction of bone carbonate. Medicine (Baltimore) 1965 Sep;44(5):397–418. doi: 10.1097/00005792-196509000-00002. [DOI] [PubMed] [Google Scholar]
- STANBURY S. W. Azotaemic renal osteodystrophy. Br Med Bull. 1957 Jan;13(1):57–60. doi: 10.1093/oxfordjournals.bmb.a069572. [DOI] [PubMed] [Google Scholar]
- Slatopolsky E., Elkan I. O., Weerts C., Bricker N. S. Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest. 1968 Mar;47(3):521–530. doi: 10.1172/JCI105748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slatopolsky E., Gradowska L., Kashemsant C., Keltner R., Manley C., Bricker N. S. The control of phosphate excretion in uremia. J Clin Invest. 1966 May;45(5):672–677. doi: 10.1172/JCI105382. [DOI] [PMC free article] [PubMed] [Google Scholar]